The pulmonary histopathology of anti-KS transfer RNA synthetase syndrome

Archives of Pathology and Laboratory Medicine

Volumn 139, Issue 1, 2015, Pages 122-125

  Schneider, Frank ^a   Aggarwal, Rohit ^b   Bi, David ^a   Gibson, Kevin ^b   Oddis, Chester ^b   Yousem, Samuel A ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b PRESBYTERIAN UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID TRANSFER RNA LIGASE; AMINOACYL TRANSFER RNA; ASPARAGINYL-TRNA SYNTHETASE; ASPARTATE TRANSFER RNA LIGASE; AUTOANTIBODY;

ADULT; CASE REPORT; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; IMMUNOLOGY; LITERATURE; LUNG; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; MYOSITIS; PATHOLOGY; REGISTER; RETROSPECTIVE STUDY;

ADULT; AMINO ACYL-TRNA SYNTHETASES; ASPARTATE-TRNA LIGASE; AUTOANTIBODIES; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; LUNG; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; MYOSITIS; REGISTRIES; RETROSPECTIVE STUDIES; REVIEW LITERATURE AS TOPIC; RNA, TRANSFER, AMINO ACYL;

EID: 84920554691     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: 10.5858/arpa.2013-0667-OA     Document Type: Article

References (20)

1. Aggarwal R, Cassidy E, Fertig N, et al. Patients with non-Jo-1 anti-tRNAsynthetase autoantibodies have worse survival than Jo-1 positive patients. Ann Rheum Dis. 2014;73(1):227-232.
2. Connors GR, Christopher-Stine L, Oddis CV, Danoff SK. Interstitial lung disease associated with the idiopathic inflammatory myopathies: what progress has been made in the past 35 years? Chest. 2010;138(6):1464-1474.
3. Cottin V, Thivolet-Bejui F, Reynaud-Gaubert M, et al. Interstitial lung disease in amyopathic dermatomyositis, dermatomyositis and polymyositis. Eur Respir J. 2003;22(2):245-250.
4. Douglas WW, Tazelaar HD, Hartman TE, et al. Polymyositis-dermatomy-ositis-associated interstitial lung disease. Am J Respir Crit Care Med. 2001;164(7): 1182-1185.
5. Kalluri M, Oddis CV. Pulmonary manifestations of the idiopathic inflammatory myopathies. Clin Chest Med. 2010;31(3):501-512.
6. Schneider F, Gruden J, Tazelaar HD, Leslie KO. Pleuropulmonary pathology in patients with rheumatic disease. Arch Pathol Lab Med. 2012; 136(10):1242-1252.
7. Tazelaar HD, Viggiano RW, Pickersgill J, Colby TV. Interstitial lung disease in polymyositis and dermatomyositis: clinical features and prognosis as correlated with histologic findings. Am Rev Respir Dis. 1990;141(3):727-733.
8. Yousem SA, Gibson K, Kaminski N, Oddis CV, Ascherman DP. The pulmonary histopathologic manifestations of the anti-Jo-1 tRNA synthetase syndrome. Mod Pathol. 2010;23(6):874-880.
9. Hamaguchi Y, Fujimoto M, Matsushita T, et al. Common and distinct clinical features in adult patients with anti-aminoacyl-tRNA synthetase antibodies: heterogeneity within the syndrome. PLoS One. 2013;8(4):e60442.
10. Targoff IN. Update on myositis-specific and myositis-associated autoantibodies. Curr Opin Rheumatol . 2000;12(6):475-481.
11. Hirakata M, Suwa A, Nagai S, et al. Anti-KS: identification of autoantibodies to asparaginyl-transfer RNA synthetase associated with interstitial lung disease. J Immunol. 1999;162(4):2315-2320.
12. Hirakata M, Suwa A, Takada T, et al. Clinical and immunogenetic features of patients with autoantibodies to asparaginyl-transfer RNA synthetase. Arthritis Rheum. 2007;56(4):1295-1303.
13. Okayasu K, Ohtani Y, Takemura T, et al. Nonspecific interstitial pneumonia (NSIP) associated with anti-KS antibody: differentiation from idiopathic NSIP. Intern Med. 2009;48(15):1301-1306.
14. Bohan A, Peter JB. Polymyositis and dermatomyositis (second of two parts). N Engl J Med. 1975;292(8):403-407.
15. Raghu G, Collard HR, Egan JJ, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011;183(6):788-824.
16. Travis WD, Costabel U, Hansell DM, et al. An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med. 2013;188(6):733-748.
17. Fathi M, Lundberg IE. Interstitial lung disease in polymyositis and dermatomyositis. Curr Opin Rheumatol. 2005;17(6):701-706.
18. Aggarwal R, Oddis CV. Therapeutic approaches in myositis. Curr Rheumatol Rep. 2011;13(3):182-191.
19. Friedman AW, Targoff IN, Arnett FC. Interstitial lung disease with autoantibodies against aminoacyl-tRNA synthetases in the absence of clinically apparent myositis. Semin Arthritis Rheum . 1996;26(1):459-467.
20. Koreeda Y, Higashimoto I, Yamamoto M, et al. Clinical and pathological findings of interstitial lung disease patients with anti-aminoacyl-tRNA synthetase autoantibodies. Intern Med. 2010;49(5):361-369.